Calendar Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 218.13 USD | +0.80% |
|
+1.78% | +9.96% |
Chart calendar Charles River Laboratories International, Inc.
Upcoming events on Charles River Laboratories International, Inc.
| 18/02/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 07/05/2026 | Q1 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 12/08/2026 | Q2 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 11/11/2026 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
Past events on Charles River Laboratories International, Inc.
| 13/01/2026 | J.P. Morgan Healthcare Conference |
| 03/12/2025 | Evercore Healthcare Conference |
| 18/11/2025 | Jefferies Global Healthcare Conference |
| 05/11/2025 | Q3 2025 Earnings Call |
| 05/11/2025 | Q3 2025 Earnings Release |
| 10/09/2025 | Baird Global Healthcare Conference |
| 09/09/2025 | Morgan Stanley Global Healthcare Conference |
| 06/08/2025 | Q2 2025 Earnings Call |
| 06/08/2025 | Q2 2025 Earnings Release |
| 04/06/2025 | Jefferies Healthcare Conference |
| 03/06/2025 | William Blair Growth Stock Conference |
| 20/05/2025 | Annual General Meeting |
| 14/05/2025 | Bank of America Global Healthcare Conference |
| 07/05/2025 | Q1 2025 Earnings Call |
| 07/05/2025 | Q1 2025 Earnings Release |
| 12/03/2025 | Barclays Global Healthcare Conference |
| 19/02/2025 | Q4 2024 Earnings Call |
| 19/02/2025 | Q4 2024 Earnings Release |
| 15/01/2025 | JP Morgan Healthcare Conference |
| 04/12/2024 | Evercore ISI HealthCONx Conference |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3 976 3 915 1.56% | 4 129 4 107 0.54% | 4 050 4 031 0.47% | 4 006 | 4 076 | 4 249 |
|
EBITDA Million USD | Released Forecast Spread | 991 982 0.87% | 1 013 1 017 -0.4% | 996 998 -0.19% | 966 | 988 | 1 042 |
|
EBIT Million USD | Released Forecast Spread | 834 820 1.67% | 839 842 -0.35% | 806 802 0.46% | 794 | 816 | 870 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 623 568 9.63% | 581 513 13.41% | 93,1 401 -76.8% | 312 | 485 | 559 |
|
Net income Million USD | Released Forecast Spread | 486 409 18.85% | 475 387 22.66% | 10,3 301 -96.58% | 215 | 381 | 440 |
|
EPS USD | Released Forecast Spread | 9,48 7,97 18.98% | 9,22 7,49 23.07% | 0,20 5,83 -96.57% | 4,19 | 7,25 | 9,22 |
| Announcement Date | 22/02/23 | 14/02/24 | 19/02/25 | - |
Quarterly results
| Fiscal Period | September | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1 012 993 1.82% | 1 026 1 024 0.18% | 1 010 975 3.51% | 1 003 984 1.92% | 984 942 4.48% | 1 032 990 4.3% | 1 005 991 1.42% | 987 | 999 | 1 031 | 1 024 | 1 016 | 1 037 | 1 063 | 1 060 |
|
EBITDA Million USD | Released Forecast Spread | 233 222 4.94% | 266 243 9.71% | 249 241 3.11% | 248 245 1.35% | 232 216 7.35% | 272 248 10.07% | 243 231 4.98% | 225 | 246 | 255 | 250 | 242 | 255 | 263 | 262 |
|
EBIT Million USD | Released Forecast Spread | 187 178 5.43% | 219 196 11.62% | 200 190 5.51% | 200 196 1.71% | 188 169 11.54% | 228 194 17.86% | 198 186 6.32% | 180 | 198 | 216 | 206 | 194 | 209 | 216 | 214 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 99,0 96,3 2.82% | 120 111 7.99% | 91,2 87,9 3.79% | -217 66,0 -428.29% | |||||||||||
|
Net income Million USD | Released Forecast Spread | 67,3 71,2 -5.45% | 90,0 83,9 7.32% | 68,7 78,2 -12.16% | -216 47,5 -553.65% | 25,5 45,3 -43.75% | 54,4 58,7 -7.21% | 68,6 | 102 | 92,8 | 123 | 102 | 121 | 115 | 130 | |
|
EPS USD | Released Forecast Spread | 1,30 1,35 -3.7% | 1,74 1,68 3.88% | 1,33 1,56 -14.88% | -4,22 1,19 -453.88% | 0,50 0,97 -48.45% | 1,06 1,38 -23.19% | 1,10 1,45 -23.96% | 1,36 | 1,92 | 2,02 | 2,39 | 2,20 | 2,49 | 2,36 | 2,67 |
| Announcement Date | 09/05/24 | 07/08/24 | 06/11/24 | 19/02/25 | 07/05/25 | 06/08/25 | 05/11/25 | - | - | - | - | - | - | - | - |
| 20/01/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 22/01/2026 | Q3 2026 Earnings Release | Add to your calendar Google Apple ICS format | |
| 28/01/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 29/01/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 03/02/2026 | Q2 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 04/02/2026 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 04/02/2026 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 09/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 10/02/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 11/02/2026 | Q1 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
Past sector events for Charles River Laboratories International, Inc.
| 12/01/2026 | December 2025 Sales and Revenue Release | |
| 09/01/2026 | December 2025 Sales and Revenue Release | |
| 08/01/2026 | December 2025 Sales and Revenue Release | |
| 24/12/2025 | Q4 2025 Earnings Release | |
| 16/12/2025 | Q3 2025 Earnings Release | |
| 12/12/2025 | Q3 2025 Earnings Release | |
| 10/12/2025 | November 2025 Sales and Revenue Release | |
| 10/12/2025 | November 2025 Sales and Revenue Release | |
| 10/12/2025 | November 2025 Sales and Revenue Release | |
| 10/12/2025 | Q3 2025 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CRL Stock
- Calendar Charles River Laboratories International, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















